Summary Damage to peripheral nerves is the major complication of reversal (type I) reactions in leprosy. The underlying mechanism of nerve damage remains largely unresolved; however, an important role for type-l T cells has been suggested. Mycobacterium Zeprae has a remarkable tropism for the Schwann cells that surround peripheral axons. Because reversal reactions in leprosy are often accompanied by severe and irreversible nerve destruction, and are associated with increased cellular immune reactivity against M. Zeprae, a likely immunopathogenic mechanism of damage to Schwann cells and peripheral nerves in leprosy is that infected Schwann cells process and present antigens of M. Zeprae to antigen-specific, inflammatory, type-l T cells, and that these T cells subsequently damage and lyse infected Schwann cells. Previous animal studies with CD8 + T cells revealed evidence for the existence of such a mechanism. A similar role has been suggested for CD4 + T cells. These latter cells may be more important in causing nerve damage in vivo, given the predilection of M. leprae for Schwann cells, and the dominant role of CD4 + , serine esterase + Thl cells in the lesions of leprosy. Antagonism of the molecular inter actions among M. Zeprae, Schwann cells and inflammatory T cells may therefore provide a rational strategy for prevention of damage of Schwann cell and nerves in leprosy.
Leprosy reactions and nerve damage
Leprosy is the leading cause of all non-traumatic peripheral neuropathies worldwide. I Although the implementation of multidrug therapy (MDT) has caused a major decline of the prevalence of leprosy wOrldwide, 2 the new-case detection rate has remained stable at a level of approximately 600,000 annually.
It is well established that host immunity to My cobacterium Zeprae dictates the clinical outcome of leprosy. It is believed that more than 99% of the population develop adequate protective immunity upon infection, and do not develop clinically detectable symptoms, 3 ,4 and only a minority of the infected individuals develop clinical leprosy.
Superimposed on the leprosy spectrum, leprosy reactions, which represent acute inflam matory episodes, can occur. Two major types of reactions are distinguished: i) erythema no do sum leprosum (ENL) (type II reactions), which occur predominantly in patients at the lepromatous end of the spectrum; and ii) reversal reactions (RR) (type I reactions), which occur particularly in patients with borderline leprosy, especially during treatment. s Type I reactions are thought to represent episodes in which cell-mediated responses to M. Zeprae are greatly enhanced, resulting in an inflammatory response in the areas of skin and nerve affected by the disease. 6 Estimates of the prevalence of RR in leprosy range from eight to 30%. 7 The enhanced cellular immune responses may be beneficial in terms of clearing bacteria, as they strengthen the mechanisms by which the organisms are killed. However, the accompanying inflammation in and around infected nerve tissue, or around nerves in close proximity to inflamed lesions can result in severe and irreversible damage within a matter of days, if treatment is inadequate. Clinically detectable neural involvement occurs in approxi mately 10% of patients with paucibacillary (PB) leprosy and 40% of those with multibacillary (MB) disease, particularly in patients with RR. 8 It has been suggested that subclinical neural involvement may occur in virtually all patients with leprosy, but that some 30% of the nerve fibres must be destroyed before sensory impairment becomes detectable. 9 A nerve fibre consists of an axon that is almost completely enveloped in a sheath of Schwann cells. Axons are either myelinated or unmyelinated. Myelinated peripheral axons possess a myelin sheath, interposed between the Schwann cells and the axon (Figure la) , that is derived from the Schwann cells themselves. Unmyelinated axons, which lack a myelin sheath, lie in deep grooves on the surface of the Schwann cells, with multiple axons enveloped by the same cell ( Figure Ib) . Externally, Schwann cells are covered by a basal lamina, which, in tum, is surrounded by endoneurial tissue. Several Schwann cell-axon units, which are embedded in endoneurium, are surrounded by the relatively impermeable perineurium, which consists of randomly oriented and highly concentrated collagen fibres. Tight junctions between the endothelial cells of the capillaries and the endothelial basement membrane separate the endoneurium from the circulation. The resulting physical 'blood-nerve barrier' is believed to be important in maintaining an appropriate physicochemical environment for the axons, and in protecting them against potentially harmful agents, including effector cells of the immune system. Nevertheless, the junctions can provide a route through which bacteria or leukocytes can ultimately enter the peripheral nervous system. identified on M. leprae. 1 7 , 1 8 This mycobacterial receptor may function as a critical surface adhesin for the G-domain of the laminin-a2 chain. Although these interactions may play a major role in the attachment of M. leprae to Schwann cells, and, perhaps, in the invasion of the Schwann cells by the organisms, it is not unlikely that other receptors may also be involved. Indeed, blocking of the dystroglycan complex could not completely inhibit the adhesion of M. leprae to Schwann cells. 16 Other candidate (co)receptors may include integrins, which are also able to bind to larninin-2, and an as yet uncharacterized 25-kDa phosphoprotein expressed by Schwann cells, to which M. leprae has been reported to bind. 19 Thus, other receptor-ligand interactions may also be involved in M. leprae-Schwann cell attachment and invasion. dependent and HLA class II-restricted (data not shown). These results show clearly that human Schwann cells can process and present M. leprae to M. leprae-specific CD4 + cytotoxic T cells, and are subsequently killed. Particularly during RR mediated by inflammatory, CD4 + T-cells, this mechanism may play an important role in causing local peripheral-nerve damage in leprosy. We propose that this represents a novel immunopathogenetic mechanism of nerve damage in leprosy.
Nerve destruction as collateral damage
In addition to nerve damage resulting from cognate T cell-Schwarm cell interactions, non specific bystander effects during inflammation may also be involved in triggering nerve damage. Possible mediators are TNFa, proteases, and urokinase. 4 o With respect to leprosy, TNFa mRNA and protein are more abundant in lesions of patients with RR. 24 , 4 1 TNFa is predominantly produced by M. leprae-responsive, type-l T cells derived from patients undergoing RR, 25 but infected and activated macrophages can also be responsible for the production. TNFa alone has little toxic effect on Schwann cells, but, in combination with transforming growth factor (TGF)-{3, it has been reported to cause significant detachment and lysis of Schwarm cells. 42 Little is known about the effect of TNFa-mediated target-killing on mycobacterial survival. TNFa-mediated lysis has been reported to have an effect on mycobacterial viability similar to that of FASIFAS-L mediated lysis, 43 but this observation is not universally accepted with respect to either FAS or TNFa.
M. leprae-specific versus autoreactive T cells in leprosy lesions
At present, which antigens are recognized by lesional T cells is unknown. Schwann cells, and, subsequently, of the nerves they surround, probably results not only from collateral damage, but also from the direct effect of CD4 + , cytolytic T cells. These T cells are instrumental in controlling the multiplication of M. leprae in lesions by activating M. leprae infected macrophages, in addition to killing the organisms. Unfortunately, however, when infected Schwann cells are killed as well, this may lead to nerve damage, which may progress to irreversible loss of peripheral nerve tissue (Figure 3 ). Although this process can involve both CD8 + 28 and CD4 + (Spierings et ai., unpublished data, 1999) cytotoxic T cells, the latter cells may be particularly important, because CD4 + T cells are present in large numbers in the centre of the granulomata of patients with RR.
